๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to assess the oral BA of TAK-831 T3 tablet for...
Status
Completed
Location
Celerion
Start Date
2018-10-18
Trial ID
NCT03706469
Treatments Being Tested
The purpose of this study is to determine whether luvadaxistat is superior ...
Status
Completed
Location
CBH Health, LLC
Start Date
2018-01-10
Trial ID
NCT03359785
Treatments Being Tested
The purpose of this study is to determine the relationship between TAK-831 ...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-21
Trial ID
NCT02716987
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, pharmacokine...
Status
Completed
Location
Clinical Research Hospital Tokyo
Start Date
2018-10-09
Trial ID
NCT03687684
The purpose of this study is to determine the pharmacokinetic (PK) of a sin...
Status
Completed
Location
PRA Health Sciences
Start Date
2017-04-04
Trial ID
NCT03101293
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of TAK...
Status
Completed
Location
California Clinical Trials Medical Group/PAREXEL
Start Date
2017-07-21
Trial ID
NCT03224325
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of TAK-831 versus pla...
Status
Completed
Location
UCLA Ataxia Center
Start Date
2017-11-08
Trial ID
NCT03214588
Treatments Being Tested
The purpose of this study is to determine ABA of TAK-831 following a single...
Status
Completed
Location
Celerion
Start Date
2020-02-17
Trial ID
NCT04234672
Treatments Being Tested
The purpose of this study is to determine whether add-on luvadaxistat is su...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2018-01-04
Trial ID
NCT03382639
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and phar...
Status
Terminated
Location
Multiple Locations
Start Date
2015-09-23
Trial ID
NCT02566759
Treatments Being Tested